| __timestamp | Insmed Incorporated | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 22570000 |
| Thursday, January 1, 2015 | 43216000 | 24378000 |
| Friday, January 1, 2016 | 50679000 | 26621000 |
| Sunday, January 1, 2017 | 79171000 | 28653000 |
| Monday, January 1, 2018 | 168218000 | 37734000 |
| Tuesday, January 1, 2019 | 210796000 | 41884000 |
| Wednesday, January 1, 2020 | 203613000 | 64435000 |
| Friday, January 1, 2021 | 234273000 | 57483000 |
| Saturday, January 1, 2022 | 265784000 | 70062000 |
| Sunday, January 1, 2023 | 344501000 | 52790000 |
Unleashing insights
In the competitive landscape of biotechnology, understanding spending patterns is crucial. Over the past decade, Insmed Incorporated has consistently outpaced Ligand Pharmaceuticals in Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking at approximately $345 million in 2023. In contrast, Ligand's growth was more modest, with a 133% increase, reaching around $70 million in 2022. This disparity highlights Insmed's aggressive investment strategy, possibly reflecting its focus on expanding market presence and operational capabilities. Meanwhile, Ligand's steadier growth suggests a more conservative approach, potentially prioritizing efficiency and cost management. These spending patterns offer a window into each company's strategic priorities and market positioning, providing valuable insights for investors and industry analysts alike.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Insmed Incorporated
Insmed Incorporated vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Insmed Incorporated and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Insmed Incorporated vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Geron Corporation
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
PTC Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Ligand Pharmaceuticals Incorporated vs Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.